REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
Guardat en:
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS. LUXEMBURGO, OFFICE FOR OFFICIAL PUBLICATIONS OF THE EUROPEAN COMMUNITIES, 1999, 33 p., 94 p.
Ref.
84714
Localització:
SIIS Q4.142 (a y b) D17.3.82 (a y b)
Palabras clave:
Cooperación internacional, Datos epidemiológicos, Declaración, Delincuencia, Directrices, Drogas de síntesis, Drogodependencias, Efectos, Informes, Innovaciones, Investigación, Recomendaciones, Riesgo, Salud, Valoración, Unión Europea
Cooperación internacional, Datos epidemiológicos, Declaración, Delincuencia, Directrices, Drogas de síntesis, Drogodependencias, Efectos, Informes, Innovaciones, Investigación, Recomendaciones, Riesgo, Salud, Valoración, Unión Europea
Ítems similars: REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF PMMA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF TMA-2 IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF KETAMINE IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF 4-MTA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS